OCGN Price / Book | OCUGEN, INC.

OCUGEN, INC. (OCGN) Price / Book

2026-03-31: Price/Book Ratio 105.49.
2025-09-30: Price/Book Ratio 144.09.
2025-06-30: Price/Book Ratio 92.87.
2025-03-31: Price/Book Ratio 12.96.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-03-31	105.49
2025-09-30	144.09
2025-06-30	92.87
2025-03-31	12.96
2024-12-31	7.92
2024-09-30	7.09
2024-06-30	23.57
2024-03-31	13.95
2023-12-31	3.64
2023-09-30	2.06
2023-06-30	2.35
2023-03-31	2.98
2022-12-31	3.89
2022-09-30	4.5
2022-06-30	4.61
2022-03-31	5.67
2021-12-31	9.95
2021-09-30	13.33
2021-06-30	13.71
2021-03-31	27.48
2020-12-31	15.63
2020-09-30	3.48
2020-06-30	2.03
2020-03-31	2.03
2019-12-31	2.48
2017-12-31	681.45
2017-06-30	2,968.57
2017-03-31	330.04
2016-12-31	152.49
2016-09-30	757.42
2016-06-30	105.67
2016-03-31	88.57
2015-12-31	98.85
2015-09-30	87.71
2015-06-30	116.96
2015-03-31	154.69
2014-12-31	155.3

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cabaletta Bio, Inc. (CABA)	United States	$0.365B	-2.81
Artiva Biotherapeutics, Inc. (ARTV)	United States	$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)	United States	$0.371B	-115.85
C4 Therapeutics, Inc. (CCCC)	United States	$0.373B	-5.65
Century Therapeutics, Inc. (IPSC)	United States	$0.306B	-4.02
SAB Biotherapeutics, Inc. (SABS)	United States	$0.306B	-25.49
AGENUS INC (AGEN)	United States	$0.383B	1.41
X4 Pharmaceuticals, Inc (XFOR)	United States	$0.297B	-4.99
Inhibikase Therapeutics, Inc. (IKT)	United States	$0.296B	-4.44
Surrozen, Inc./DE (SRZN)	United States	$0.395B